Skip navigation
× You've used up your 3 free articles for this month. Subscribe today.

California Prisoners File Class-action Suit Seeking Hepatitis C Treatment

by Gregory Dober

In 2013, the FDA approved two new life-saving hepatitis C (HCV) drugs known as simeprevir (brand named Olysio) and sofosbuvir (brand named Sovaldi). The drugs, a new class of medication called direct-acting antivirals (DAAs), were proven to be over 90% effective in clinical trials. Additionally, they reduced ...

 

Full article and associated cases available to subscribers.

As a digital subscriber to Prison Legal News, you can access full text and downloads for this and other premium content.

Subscribe today

Already a subscriber? Login